Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
9.35
Dollar change
-0.26
Percentage change
-2.71
%
IndexRUT P/E- EPS (ttm)-2.77 Insider Own4.42% Shs Outstand160.09M Perf Week-4.05%
Market Cap1.46B Forward P/E262.79 EPS next Y0.04 Insider Trans-1.07% Shs Float153.03M Perf Month-35.16%
Income-294.33M PEG- EPS next Q-0.83 Inst Own53.29% Short Float23.34% Perf Quarter-17.84%
Sales987.67M P/S1.47 EPS this Y81.38% Inst Trans10.87% Short Ratio5.79 Perf Half Y89.66%
Book/sh-2.70 P/B- EPS next Y103.53% ROA-16.80% Short Interest35.72M Perf Year33.57%
Cash/sh6.81 P/C1.37 EPS next 5Y37.90% ROE- 52W Range3.53 - 23.86 Perf YTD94.79%
Dividend Est.- P/FCF- EPS past 5Y11.55% ROI- 52W High-60.81% Beta2.09
Dividend TTM- Quick Ratio1.03 Sales past 5Y513.29% Gross Margin66.32% 52W Low164.69% ATR (14)0.77
Dividend Ex-DateDec 13, 2007 Current Ratio1.04 EPS Y/Y TTM62.96% Oper. Margin-28.95% RSI (14)32.50 Volatility5.89% 5.93%
Employees1543 Debt/Eq- Sales Y/Y TTM-38.17% Profit Margin-29.80% Recom2.60 Target Price17.60
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q70.87% Payout- Rel Volume0.69 Prev Close9.61
Sales Surprise-9.40% EPS Surprise-40.72% Sales Q/Q-2.11% EarningsAug 08 BMO Avg Volume6.17M Price9.35
SMA20-14.66% SMA50-21.49% SMA200-4.62% Trades Volume4,266,813 Change-2.71%
Date Action Analyst Rating Change Price Target Change
Jul-30-24Downgrade JP Morgan Neutral → Underweight $8
May-10-24Upgrade JP Morgan Underweight → Neutral
May-10-24Upgrade BofA Securities Underperform → Neutral $4 → $12
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
Nov-01-24 09:00AM
Oct-31-24 04:09PM
Oct-29-24 05:45PM
Oct-26-24 12:29PM
12:29PM
05:45PM Loading…
Oct-23-24 05:45PM
Oct-22-24 04:00AM
Oct-21-24 09:00AM
07:45AM
Oct-19-24 06:15PM
Oct-17-24 05:45PM
10:07AM
08:18AM
07:08AM
Oct-16-24 04:34PM
03:50PM Loading…
03:50PM
01:20PM
11:58AM
10:56AM
10:30AM
10:07AM
09:45AM
09:16AM
08:14AM
Oct-14-24 05:19AM
Oct-11-24 01:36PM
Oct-10-24 05:45PM
Oct-09-24 05:33PM
07:00AM
Oct-08-24 09:00AM
05:49AM Loading…
Oct-07-24 05:49AM
Oct-06-24 01:41PM
Oct-03-24 05:45PM
03:27AM
Sep-26-24 11:39AM
Sep-25-24 09:00AM
08:00AM
Sep-23-24 05:45PM
01:15PM
Sep-17-24 05:07PM
Sep-16-24 07:52AM
Sep-13-24 01:09PM
09:25AM
07:50AM
Sep-11-24 09:00AM
Sep-05-24 10:00AM
Sep-04-24 09:25AM
09:15AM
Sep-03-24 09:35AM
Sep-02-24 10:53AM
07:34AM
Aug-30-24 04:47PM
04:19PM
04:06PM
Aug-29-24 12:00PM
Aug-28-24 09:00AM
Aug-24-24 11:20AM
Aug-22-24 02:33PM
01:41PM
Aug-14-24 09:00AM
Aug-09-24 11:09AM
Aug-08-24 12:08PM
09:15AM
08:11AM
08:02AM
07:47AM
07:20AM
Aug-05-24 10:19AM
Aug-03-24 05:29AM
Aug-01-24 05:45PM
09:25AM
08:15AM
Jul-31-24 11:52AM
Jul-30-24 04:55PM
04:05PM
Jul-29-24 09:00AM
Jul-25-24 01:28PM
Jul-23-24 09:41AM
Jul-16-24 09:00AM
Jul-15-24 09:30AM
Jul-08-24 05:45PM
Jul-03-24 06:55AM
Jul-02-24 08:30AM
Jul-01-24 11:00PM
07:38AM
Jun-29-24 08:55AM
08:35AM
Jun-28-24 05:45PM
06:30AM
Jun-27-24 02:21PM
Jun-25-24 07:00PM
04:37PM
11:42AM
06:33AM
Jun-24-24 09:18AM
09:00AM
Jun-22-24 03:42AM
Jun-20-24 05:45PM
Jun-18-24 10:29AM
05:52AM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dubovsky FilipOfficerSep 18 '24Proposed Sale13.007,33595,331Sep 18 04:08 PM
Trizzino JohnEVP, CCO and CBOAug 19 '24Option Exercise0.00655028,627Aug 21 04:47 PM
Kelly James PatrickEVP, CFO and TreasurerAug 16 '24Option Exercise12.962,36730,67615,652Aug 20 05:06 PM
YOUNG JAMES FDirectorJun 21 '24Sale14.097,500105,67561,760Jun 25 04:12 PM
YOUNG JAMES FDirectorJun 18 '24Sale13.727,500102,88169,260Jun 21 04:21 PM
Dubovsky FilipPresident, R&DJun 17 '24Option Exercise6.1813,90485,91180,517Jun 20 05:08 PM
Dubovsky FilipPresident, R&DJun 17 '24Sale14.4713,904201,16466,613Jun 20 05:08 PM
MCGLYNN MARGARET GDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:14 PM
Alton Gregg HDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:11 PM
DOUGLAS RICHARDDirectorJun 12 '24Option Exercise0.006,670043,920Jun 14 04:10 PM
King Rachel K.DirectorJun 12 '24Option Exercise0.006,670018,920Jun 14 04:07 PM
MOTT DAVID MDirectorJun 12 '24Option Exercise0.006,670050,470Jun 14 04:06 PM
Rodgers Richard JDirectorJun 12 '24Option Exercise0.006,670010,470Jun 14 04:05 PM
YOUNG JAMES FDirectorJun 12 '24Option Exercise0.006,670076,760Jun 14 04:01 PM
Dubovsky FilipPresident, R&DMay 14 '24Option Exercise6.9719,652136,97486,265May 15 09:15 PM
Dubovsky FilipPresident, R&DMay 14 '24Sale13.9047,312657,63738,953May 15 09:15 PM
O'Hara ElaineEVP, Chief Strategy OfficerMar 01 '24Option Exercise5.3919,600105,64419,600Mar 05 07:30 PM
Dubovsky FilipPresident, R&DDec 14 '23Option Exercise5.692,83316,12055,150Dec 18 05:00 PM
Dubovsky FilipPresident, R&DNov 05 '23Option Exercise7.061,4009,88452,994Nov 07 05:30 PM